您好, 歡迎來到化工儀器網(wǎng)! 登錄| 免費(fèi)注冊(cè)| 產(chǎn)品展廳| 收藏商鋪|
英國(guó)NIBSC標(biāo)準(zhǔn)品是深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司的熱銷產(chǎn)品,主要應(yīng)用在哪些領(lǐng)域呢?
英國(guó)國(guó)家生物制品檢定所是WHO的一個(gè)標(biāo)準(zhǔn)品供應(yīng)中心實(shí)驗(yàn)室,它的核心工作是制備、保存和分發(fā)WHO用于檢測(cè)生物制品質(zhì)量的標(biāo)準(zhǔn)品。NIBSC制備的流感毒株和檢測(cè)抗原、抗血清標(biāo)準(zhǔn)品,保障了各廠家順利的研究和生產(chǎn)。NIBSC提供對(duì)投入英國(guó)市場(chǎng)的生物藥品的獨(dú)立測(cè)試,尤其是用于英國(guó)兒童免疫計(jì)劃的疫苗;它同時(shí)也是歐盟控制藥品進(jìn)入歐盟市場(chǎng)的藥品控制實(shí)驗(yàn)室(OMCL)。 如果出現(xiàn)不能滿足藥品存放要求或患者出現(xiàn)不良反應(yīng)等問題,NIBSC 也可對(duì)已投入歐盟市場(chǎng)的產(chǎn)品進(jìn)行檢驗(yàn)。
NIBSC 戰(zhàn)略目標(biāo):對(duì)有關(guān)生物產(chǎn)品的問題給出回復(fù)和建議;提供生物藥品方面的國(guó)家科技力量,維持滿足科學(xué)和藥物學(xué)領(lǐng)域新發(fā)展需求的靈活性、專業(yè)知識(shí)和設(shè)施;
作為化驗(yàn)方法(如量化生物學(xué)活性以及確定生物產(chǎn)品特征和進(jìn)行安全評(píng)估)方面的機(jī)構(gòu)運(yùn)營(yíng)并得到認(rèn)同;
在歐洲生物產(chǎn)品的控制和標(biāo)準(zhǔn)化方面,繼續(xù)發(fā)揮科學(xué)基礎(chǔ)開發(fā)的中心作用;
在生物藥品法規(guī)的科學(xué)方面幫助社會(huì)達(dá)成共識(shí),并籍于此,與世界衛(wèi)生組織緊密合作;
在控制和標(biāo)準(zhǔn)化的關(guān)鍵領(lǐng)域?qū)崿F(xiàn)和維護(hù)質(zhì)量鑒定。
生物藥品控制
藥品中使用的生物物質(zhì)包括病毒和細(xì)菌疫苗、從人類血液提取的產(chǎn)物、荷爾蒙以及其它諸如細(xì)胞分裂素和生長(zhǎng)素等治療藥物。
這些生物物質(zhì)對(duì)藥物學(xué)和公眾健康做出了巨大貢獻(xiàn)并發(fā)揮著越來越大的作用,它們大大改善了*的疾病預(yù)防、診斷和治療。
英國(guó)NIBSC標(biāo)準(zhǔn)品部分產(chǎn)品列表:
(篇幅有限,更多產(chǎn)品,歡迎進(jìn)入我司展臺(tái)查詢)
01/491 | Meningococcal serogroup W polysaccharide |
13/240 | Influenza Antigen B/Massachusetts/02/2118 (Egg derived) |
12/B623-034 | QCRFLUAH1N1QC1-Influenza AH1N1 QC32 |
95/634 | Interleukin-95 (Human, rDNA derived) |
10/211 | Reteplase Reference Material |
12/B623-023 | QCRFLUAH1N1QC1-Influenza AH1N1 QC21 |
13/242 | Polio Anti Sabin type 25 (inactivated) Serum |
95/587 | Interleukin-48 (Human, rDNA derived) |
10/107 | Reteplase Reference Material |
13/202 | C-Peptide, Human. 57st International Standard. |
95/644 | Interleukin-105 (Human, rDNA derived) |
12/B623-096 | QCRFLUAH1N1QC1-Influenza AH1N1 QC94 |
13/313 | Polio Anti Sabin type 96 (inactivated) Serum |
95/556 | Interleukin-17 (Human, rDNA derived) |
13/317 | Polio Anti Sabin type 100 (inactivated) Serum |
95/562 | Interleukin-23 (Human, rDNA derived) |
12/B623-077 | QCRFLUAH1N1QC1-Influenza AH1N1 QC75 |
12/B623-033 | QCRFLUAH1N1QC1-Influenza AH1N1 QC31 |
13/165 | C-Peptide, Human. 20st International Standard. |
13/248 | Polio Anti Sabin type 31 (inactivated) Serum |
01/520 | Meningococcal serogroup W polysaccharide |
10/207 | Reteplase Reference Material |
03/104-065 | HTLV-50 (antibody) Monitor Sample |
12/B623-098 | QCRFLUAH1N1QC1-Influenza AH1N1 QC96 |
13/272 | Polio Anti Sabin type 55 (inactivated) Serum |
03/104-034 | HTLV-19 (antibody) Monitor Sample |
01/478 | Meningococcal serogroup W polysaccharide |
95/659 | Interleukin-120 (Human, rDNA derived) |
95/592 | Interleukin-53 (Human, rDNA derived) |
95/579 | Interleukin-40 (Human, rDNA derived) |
13/156 | Influenza Antigen B/Massachusetts/02/2034 (Egg derived) |
07/339 | BCG Vaccine of Russian BCG-I sub-strain(66st WHO Reference Reagent) |
95/565 | Interleukin-26 (Human, rDNA derived) |
01/429 | Meningococcal serogroup W polysaccharide |
01/441 | Meningococcal serogroup W polysaccharide |
12/B623-110 | QCRFLUAH1N1QC1-Influenza AH1N1 QC108 |
10/116 | Reteplase Reference Material |
12/B623-025 | QCRFLUAH1N1QC1-Influenza AH1N1 QC23 |
10/156 | Reteplase Reference Material |
07/358 | BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent) |
12/B623-020 | QCRFLUAH1N1QC1-Influenza AH1N1 QC18 |
01/497 | Meningococcal serogroup W polysaccharide |
13/174 | C-Peptide, Human. 29st International Standard. |
13/196 | Influenza Antigen B/Massachusetts/02/2074 (Egg derived) |
12/B623-062 | QCRFLUAH1N1QC1-Influenza AH1N1 QC60 |
10/193 | Reteplase Reference Material |
13/143 | Influenza Antigen B/Massachusetts/02/2021 (Egg derived) |
07/381 | BCG Vaccine of Russian BCG-I sub-strain(108st WHO Reference Reagent) |
01/528 | Meningococcal serogroup W polysaccharide |
03/104-074 | HTLV-59 (antibody) Monitor Sample |
01/507 | Meningococcal serogroup W polysaccharide |
01/526 | Meningococcal serogroup W polysaccharide |
13/167 | Influenza Antigen B/Massachusetts/02/2045 (Egg derived) |
01/530 | Meningococcal serogroup W polysaccharide |
13/193 | Influenza Antigen B/Massachusetts/02/2071 (Egg derived) |
03/104-118 | HTLV-103 (antibody) Monitor Sample |
03/104-069 | HTLV-54 (antibody) Monitor Sample |
03/104-083 | HTLV-68 (antibody) Monitor Sample |
07/318 | BCG Vaccine of Russian BCG-I sub-strain(45st WHO Reference Reagent) |
12/B623-097 | QCRFLUAH1N1QC1-Influenza AH1N1 QC95 |
10/210 | Reteplase Reference Material |
13/222 | Influenza Antigen B/Massachusetts/02/2100 (Egg derived) |
10/140 | Reteplase Reference Material |
07/291 | BCG Vaccine of Russian BCG-I sub-strain(18st WHO Reference Reagent) |
13/183 | Influenza Antigen B/Massachusetts/02/2061 (Egg derived) |
13/224 | Influenza Antigen B/Massachusetts/02/2102 (Egg derived) |
10/104 | Reteplase Reference Material |
10/200 | Reteplase Reference Material |
13/245 | C-Peptide, Human. 100st International Standard. |
03/104-043 | HTLV-28 (antibody) Monitor Sample |
07/361 | BCG Vaccine of Russian BCG-I sub-strain(88st WHO Reference Reagent) |
01/513 | Meningococcal serogroup W polysaccharide |
03/104-120 | HTLV-105 (antibody) Monitor Sample |
13/209 | C-Peptide, Human. 64st International Standard. |
03/104-018 | HTLV-3 (antibody) Monitor Sample |
95/618 | Interleukin-79 (Human, rDNA derived) |
07/348 | BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent) |
10/201 | Reteplase Reference Material |
12/B623-027 | QCRFLUAH1N1QC1-Influenza AH1N1 QC25 |
07/315 | BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent) |
12/B623-040 | QCRFLUAH1N1QC1-Influenza AH1N1 QC38 |
13/187 | Influenza Antigen B/Massachusetts/02/2065 (Egg derived) |
13/306 | Polio Anti Sabin type 89 (inactivated) Serum |
03/104-108 | HTLV-93 (antibody) Monitor Sample |
07/327 | BCG Vaccine of Russian BCG-I sub-strain(54st WHO Reference Reagent) |
13/158 | C-Peptide, Human. 13st International Standard. |
12/B623-010 | QCRFLUAH1N1QC1-Influenza AH1N1 QC8 |
07/294 | BCG Vaccine of Russian BCG-I sub-strain(21st WHO Reference Reagent) |
13/319 | Polio Anti Sabin type 102 (inactivated) Serum |
03/104-089 | HTLV-74 (antibody) Monitor Sample |
13/172 | C-Peptide, Human. 27st International Standard. |
13/224 | C-Peptide, Human. 79st International Standard. |
01/512 | Meningococcal serogroup W polysaccharide |
01/469 | Meningococcal serogroup W polysaccharide |
13/235 | C-Peptide, Human. 90st International Standard. |
12/B623-082 | QCRFLUAH1N1QC1-Influenza AH1N1 QC80 |
13/151 | C-Peptide, Human. 6st International Standard. |
13/211 | C-Peptide, Human. 66st International Standard. |
01/436 | Meningococcal serogroup W polysaccharide |
10/135 | Reteplase Reference Material |
03/104-032 | HTLV-17 (antibody) Monitor Sample |
95/630 | Interleukin-91 (Human, rDNA derived) |
07/319 | BCG Vaccine of Russian BCG-I sub-strain(46st WHO Reference Reagent) |
13/240 | Polio Anti Sabin type 23 (inactivated) Serum |
95/608 | Interleukin-69 (Human, rDNA derived) |
13/315 | Polio Anti Sabin type 98 (inactivated) Serum |
95/614 | Interleukin-75 (Human, rDNA derived) |
07/338 | BCG Vaccine of Russian BCG-I sub-strain(65st WHO Reference Reagent) |
07/336 | BCG Vaccine of Russian BCG-I sub-strain(63st WHO Reference Reagent) |
13/174 | Influenza Antigen B/Massachusetts/02/2052 (Egg derived) |
07/307 | BCG Vaccine of Russian BCG-I sub-strain(34st WHO Reference Reagent) |
03/104-092 | HTLV-77 (antibody) Monitor Sample |
95/629 | Interleukin-90 (Human, rDNA derived) |
13/226 | Polio Anti Sabin type 9 (inactivated) Serum |
01/532 | Meningococcal serogroup W polysaccharide |
07/345 | BCG Vaccine of Russian BCG-I sub-strain(72st WHO Reference Reagent) |
01/476 | Meningococcal serogroup W polysaccharide |
03/104-101 | HTLV-86 (antibody) Monitor Sample |
13/216 | C-Peptide, Human. 71st International Standard. |
13/324 | Polio Anti Sabin type 107 (inactivated) Serum |
07/275 | BCG Vaccine of Russian BCG-I sub-strain(2st WHO Reference Reagent) |
13/226 | Influenza Antigen B/Massachusetts/02/2104 (Egg derived) |
03/104-024 | HTLV-9 (antibody) Monitor Sample |
01/468 | Meningococcal serogroup W polysaccharide |
07/325 | BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent) |
12/B623-038 | QCRFLUAH1N1QC1-Influenza AH1N1 QC36 |
12/B623-047 | QCRFLUAH1N1QC1-Influenza AH1N1 QC45 |
13/271 | Polio Anti Sabin type 54 (inactivated) Serum |
95/610 | Interleukin-71 (Human, rDNA derived) |
01/450 | Meningococcal serogroup W polysaccharide |
07/279 | BCG Vaccine of Russian BCG-I sub-strain(6st WHO Reference Reagent) |
01/442 | Meningococcal serogroup W polysaccharide |
12/B623-057 | QCRFLUAH1N1QC1-Influenza AH1N1 QC55 |
10/136 | Reteplase Reference Material |
12/B623-006 | QCRFLUAH1N1QC1-Influenza AH1N1 QC4 |
07/351 | BCG Vaccine of Russian BCG-I sub-strain(78st WHO Reference Reagent) |
13/178 | Influenza Antigen B/Massachusetts/02/2056 (Egg derived) |
13/285 | Polio Anti Sabin type 68 (inactivated) Serum |
03/104-091 | HTLV-76 (antibody) Monitor Sample |
01/471 | Meningococcal serogroup W polysaccharide |
13/181 | C-Peptide, Human. 36st International Standard. |
03/104-095 | HTLV-80 (antibody) Monitor Sample |
10/110 | Reteplase Reference Material |
10/143 | Reteplase Reference Material |
13/137 | Influenza Antigen B/Massachusetts/02/2015 (Egg derived) |
07/349 | BCG Vaccine of Russian BCG-I sub-strain(76st WHO Reference Reagent) |
07/304 | BCG Vaccine of Russian BCG-I sub-strain(31st WHO Reference Reagent) |
13/242 | C-Peptide, Human. 97st International Standard. |
12/B623-017 | QCRFLUAH1N1QC1-Influenza AH1N1 QC15 |
07/321 | BCG Vaccine of Russian BCG-I sub-strain(48st WHO Reference Reagent) |
10/115 | Reteplase Reference Material |
13/228 | Influenza Antigen B/Massachusetts/02/2106 (Egg derived) |
12/B623-029 | QCRFLUAH1N1QC1-Influenza AH1N1 QC27 |
10/165 | Reteplase Reference Material |
13/218 | C-Peptide, Human. 73st International Standard. |
12/B623-070 | QCRFLUAH1N1QC1-Influenza AH1N1 QC68 |
13/200 | Influenza Antigen B/Massachusetts/02/2078 (Egg derived) |
03/104-084 | HTLV-69 (antibody) Monitor Sample |
95/624 | Interleukin-85 (Human, rDNA derived) |
01/499 | Meningococcal serogroup W polysaccharide |
03/104-098 | HTLV-83 (antibody) Monitor Sample |
13/235 | Influenza Antigen B/Massachusetts/02/2113 (Egg derived) |
01/516 | Meningococcal serogroup W polysaccharide |
13/162 | C-Peptide, Human. 17st International Standard. |
13/152 | Influenza Antigen B/Massachusetts/02/2030 (Egg derived) |
請(qǐng)輸入賬號(hào)
請(qǐng)輸入密碼
請(qǐng)輸驗(yàn)證碼
以上信息由企業(yè)自行提供,信息內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由相關(guān)企業(yè)負(fù)責(zé),化工儀器網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。
溫馨提示:為規(guī)避購(gòu)買風(fēng)險(xiǎn),建議您在購(gòu)買產(chǎn)品前務(wù)必確認(rèn)供應(yīng)商資質(zhì)及產(chǎn)品質(zhì)量。